Fairmount Funds Management LLC's Net Worth
Estimate Recalculated Nov 11, 2024 01:52PM EST
Who is Fairmount Funds Management LLC
Fairmount Funds Management LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., Viridian Therapeutics, Inc.\DE, Cogent Biosciences, Inc., Spyre Therapeutics, Inc., Dianthus Therapeutics, Inc. /DE/, and Oruka Therapeutics, Inc..
SEC CIK
Fairmount Funds Management LLC's CIK is 0001802528
Past Insider Trading and Trends
2023 was Fairmount Funds Management LLC's most active year for acquiring shares with 2 total transactions. Fairmount Funds Management LLC's most active month to acquire stocks was the month of May. 2023 saw Fairmount Funds Management LLC paying a total of $0.00 for 95,516 shares, this is the most they've acquired in one year.
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
